BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2005
View Archived Issues
Series A financing at Actimis
Read More
FLT3 tyrosine kinase inhibitor eradicates tumors in mice
Read More
JUN-1111 inhibits Cdc25 by selective and irreversible oxidation
Read More
NGF gene therapy shows promise in the treatment of Alzheimer's disease
Read More
Promising phase II data reported for P1A in the prevention of antibiotic resistance
Read More
Activation of PKC-delta with PEP-005 results in antileukemic effects in vitro
Read More
Exelixis submits IND for XL-844
Read More
YM BioSciences completes purchase of Delex Therapeutics
Read More
Roche makes milestone payment to retain option to MEM-3454
Read More
Extension of Metabolex and Astellas' diabetes and obesity collaboration
Read More
New therapies for neurological disorders claimed in recent patent literature
Read More
Novel HIV reverse transcriptase inhibitors emerge from Gilead R&D
Read More
Novel antithrombotic therapies claimed by Arena, Yamanouchi and Rovi
Read More
Large Scale Biology seeks orphan drug status for lysosomal acid lipase product
Read More
Preliminary data on the efficacy of Flurizan in Alzheimer's disease
Read More
European orphan drug designation for ambrisentan
Read More
Improved tocolytic effects found for barusiban in a model of preterm labor
Read More
Priority review for Increlex NDA
Read More
New follow-on phase II study of M-40403 and morphine in postsurgical pain
Read More
Enrollment begins for phase II prostate cancer trial of AP-23573
Read More
Endovasc discusses Liprostin with the FDA
Read More
Helix identifies lead product candidate from DOS-47 cancer therapeutic program
Read More
InKine submits NDA for next generation purgative product
Read More
Botulinum toxin type A demonstrates potential in chronic daily headache
Read More
Boostrix receives FDA approval
Read More
Prous Science expands webcast coverage of the 2005 FDA Science Forum
Read More